Quality of life in children with sickle cell hemoglobinopathy

Archana B Patel1, Habib G Pathan

  • 1Indira Gandhi Medical College, Nagpur, India. archana@giasbm01.vsnl.net.in

Insights

Quality of life (QOL) is significantly impacted in children with sickle cell anemia (SCA) and sickle cell trait (SCT). Interventions should address physical, psychosocial, and cognitive domains affected by these conditions.

Area of Science:

  • Pediatric Hematology
  • Quality of Life Research
  • Genetics

Background:

  • Sickle cell disease (SCD) and sickle cell trait (SCT) are genetic blood disorders with significant health implications.
  • Understanding the impact of SCD and SCT on children's daily lives is crucial for effective management.
  • Previous research has highlighted various challenges faced by individuals with SCD, but comprehensive QOL assessments in pediatric populations require further investigation.

Purpose of the Study:

  • To evaluate and compare the quality of life (QOL) domains in children with sickle cell anemia (SCA), sickle cell trait (SCT), and healthy controls.
  • To identify specific areas of physical, psychosocial, and cognitive functioning most affected by SCA and SCT in children aged 8-14 years.

Main Methods:

  • A cross-sectional study involving 52 children aged 8-14 years at a regional hemoglobinopathy center.
  • Participants were categorized into three groups: 25 with SCA, 12 with SCT, and 15 as normal controls.
  • Quality of life (QOL) was assessed using a multidimensional interview-based questionnaire.

Main Results:

  • Children with SCA experienced significant impairments across all QOL domains, particularly in physical activities like playing and mobility.
  • Psychosocial aspects, including sadness, lack of teacher support, and reduced participation in social/cultural activities, were also affected in SCA.
  • Notably, children with SCT also exhibited affected QOL across all domains compared to controls, potentially due to disease stigma.

Conclusions:

  • Quality of life (QOL) is demonstrably reduced in children with sickle cell disease (SCD) and, to a lesser extent, in those with sickle cell trait (SCT).
  • Targeted interventions focusing on identified QOL deficits are recommended for children with SCD.
  • Enhancing awareness about SCD and SCT manifestations can help mitigate the psychosocial burden on affected children, especially those with SCT.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...